CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: antimony atom
Accession: CHEBI:30513
browse the term
Definition: A pnictogen that has formula Sb.
Synonyms: related_synonym: 51Sb; Antimon; Formula=Sb; InChI=1S/Sb; InChIKey=WATWJIUSRGPENY-UHFFFAOYSA-N; SMILES=[Sb]; Sb; antimoine; antimonio; antimony; stibium
xref: WebElements:Sb
G
ABCC2
ATP binding cassette subfamily C member 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ABCC2 mRNA
CTD
PMID:32076005
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCC3
ATP binding cassette subfamily C member 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ABCC3 mRNA
CTD
PMID:32076005
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
G
AKR1B10
aldo-keto reductase family 1 member B10
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1B10 mRNA
CTD
PMID:32076005
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
G
AKR1C3
aldo-keto reductase family 1 member C3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1C3 mRNA
CTD
PMID:32076005
NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
G
ALDH3A2
aldehyde dehydrogenase 3 family member A2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ALDH3A2 mRNA
CTD
PMID:32076005
NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760
G
ALDH3B2
aldehyde dehydrogenase 3 family member B2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ALDH3B2 mRNA
CTD
PMID:32076005
NCBI chr11:67,662,155...67,681,252
Ensembl chr11:67,662,155...67,681,224
G
BARX2
BARX homeobox 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BARX2 mRNA
CTD
PMID:32076005
NCBI chr11:129,375,233...129,452,279
Ensembl chr11:129,375,848...129,452,279
G
BMP4
bone morphogenetic protein 4
multiple interactions decreases expression
EXP
RTKI cpd inhibits the reaction [antimonite results in decreased expression of BMP4 mRNA]
CTD
PMID:17400267
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
G
BTF3
basic transcription factor 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTF3 mRNA
CTD
PMID:32076005
NCBI chr 5:73,498,442...73,505,667
Ensembl chr 5:73,498,408...73,505,667
G
BTG2
BTG anti-proliferation factor 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTG2 mRNA
CTD
PMID:32076005
NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
G
CALR
calreticulin
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CALR mRNA
CTD
PMID:32076005
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
G
CBR1
carbonyl reductase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA
CTD
PMID:32076005
NCBI chr21:36,070,024...36,073,164
Ensembl chr21:36,069,941...36,073,166
G
CDKN2B
cyclin dependent kinase inhibitor 2B
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CDKN2B mRNA
CTD
PMID:32076005
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
G
CEBPA
CCAAT enhancer binding protein alpha
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CEBPA mRNA
CTD
PMID:32076005
NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
G
CNBP
CCHC-type zinc finger nucleic acid binding protein
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CNBP mRNA
CTD
PMID:32076005
NCBI chr 3:129,167,827...129,183,896
Ensembl chr 3:129,167,827...129,183,922
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CYP1B1 mRNA
CTD
PMID:32076005
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
DHRS9
dehydrogenase/reductase 9
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DHRS9 mRNA
CTD
PMID:32076005
NCBI chr 2:169,067,077...169,096,167
Ensembl chr 2:169,064,789...169,096,167
G
DNAJB1
DnaJ heat shock protein family (Hsp40) member B1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DNAJB1 mRNA
CTD
PMID:32076005
NCBI chr19:14,514,769...14,560,391
Ensembl chr19:14,514,769...14,560,391
G
DNAJB4
DnaJ heat shock protein family (Hsp40) member B4
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of DNAJB4 mRNA
CTD
PMID:32076005
NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
G
DSC1
desmocollin 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSC1 mRNA; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSC1 mRNA]
CTD
PMID:32076005
NCBI chr18:31,129,236...31,162,856
Ensembl chr18:31,129,236...31,162,856
G
DSG1
desmoglein 1
multiple interactions
EXP
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]
CTD
PMID:32076005
NCBI chr18:31,318,160...31,359,246
Ensembl chr18:31,318,160...31,359,246
G
EGFR
epidermal growth factor receptor
increases expression
EXP
antimonite results in increased expression of EGFR protein
CTD
PMID:17400267
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
EGR3
early growth response 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EGR3 mRNA
CTD
PMID:32076005
NCBI chr 8:22,687,659...22,693,480
Ensembl chr 8:22,687,659...22,693,480
G
EHF
ETS homologous factor
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EHF mRNA
CTD
PMID:32076005
NCBI chr11:34,621,093...34,663,288
Ensembl chr11:34,621,093...34,663,288
G
ELF3
E74 like ETS transcription factor 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ELF3 mRNA
CTD
PMID:32076005
NCBI chr 1:202,010,587...202,017,183
Ensembl chr 1:202,007,945...202,017,183
G
EPHA1
EPH receptor A1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA1 protein
CTD
PMID:32076005
NCBI chr 7:143,391,129...143,408,856
Ensembl chr 7:143,390,289...143,408,856
G
EPHA2
EPH receptor A2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA2 protein
CTD
PMID:32076005
NCBI chr 1:16,124,337...16,156,069
Ensembl chr 1:16,124,337...16,156,069
G
EPHX1
epoxide hydrolase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of EPHX1 mRNA
CTD
PMID:32076005
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
FGFR3
fibroblast growth factor receptor 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FGFR3 mRNA
CTD
PMID:32076005
NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872
G
FLG
filaggrin
multiple interactions
EXP
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]
CTD
PMID:32076005
NCBI chr 1:152,302,165...152,325,239
Ensembl chr 1:152,302,165...152,325,239
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FOS mRNA
CTD
PMID:32076005
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FOXQ1
forkhead box Q1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FOXQ1 mRNA
CTD
PMID:32076005
NCBI chr 6:1,312,098...1,314,758
Ensembl chr 6:1,312,098...1,314,758
G
FTH1
ferritin heavy chain 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of FTH1 mRNA
CTD
PMID:32076005
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
G
FTL
ferritin light chain
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of FTL mRNA
CTD
PMID:32076005
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
G
GCLC
glutamate-cysteine ligase catalytic subunit
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLC mRNA
CTD
PMID:32076005
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLM mRNA
CTD
PMID:32076005
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GGT1
gamma-glutamyltransferase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GGT1 mRNA
CTD
PMID:32076005
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
G
GLRX
glutaredoxin
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GLRX mRNA
CTD
PMID:32076005
NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
G
GPX2
glutathione peroxidase 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GPX2 mRNA
CTD
PMID:32076005
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
GRHL1
grainyhead like transcription factor 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of GRHL1 mRNA
CTD
PMID:32076005
NCBI chr 2:9,951,693...10,002,277
Ensembl chr 2:9,951,693...10,002,277
G
GSTO1
glutathione S-transferase omega 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GSTO1 mRNA
CTD
PMID:32076005
NCBI chr10:104,254,173...104,267,455
Ensembl chr10:104,235,356...104,267,459
G
HLTF
helicase like transcription factor
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HLTF mRNA
CTD
PMID:32076005
NCBI chr 3:149,030,063...149,086,533
Ensembl chr 3:149,030,127...149,086,554
G
HMOX1
heme oxygenase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HMOX1 mRNA
CTD
PMID:32076005
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HOPX
HOP homeobox
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of HOPX mRNA
CTD
PMID:32076005
NCBI chr 4:56,647,998...56,681,706
Ensembl chr 4:56,647,988...56,681,899
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPA1A mRNA
CTD
PMID:32076005
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
HSPA8
heat shock protein family A (Hsp70) member 8
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPA8 mRNA
CTD
PMID:32076005
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
HSPB8
heat shock protein family B (small) member 8
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPB8 mRNA
CTD
PMID:32076005
NCBI chr12:119,178,931...119,194,746
Ensembl chr12:119,171,555...119,224,855
G
HTATIP2
HIV-1 Tat interactive protein 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HTATIP2 mRNA
CTD
PMID:32076005
NCBI chr11:20,363,714...20,383,782
Ensembl chr11:20,363,685...20,383,782
G
ID1
inhibitor of DNA binding 1, HLH protein
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ID1 mRNA
CTD
PMID:32076005
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
G
IKZF2
IKAROS family zinc finger 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IKZF2 mRNA
CTD
PMID:32076005
NCBI chr 2:212,999,698...213,152,456
Ensembl chr 2:212,999,691...213,152,427
G
IL1RN
interleukin 1 receptor antagonist
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IL1RN mRNA
CTD
PMID:32076005
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IVL
involucrin
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IVL mRNA
CTD
PMID:32076005
NCBI chr 1:152,908,546...152,911,886
Ensembl chr 1:152,908,546...152,911,886
G
KLF5
Kruppel like factor 5
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KLF5 mRNA
CTD
PMID:32076005
NCBI chr13:73,054,976...73,077,538
Ensembl chr13:73,054,976...73,077,541
G
KRT1
keratin 1
multiple interactions
EXP
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]
CTD
PMID:32076005
NCBI chr12:52,674,736...52,680,407
Ensembl chr12:52,674,736...52,680,407
G
KRT10
keratin 10
multiple interactions
EXP
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]
CTD
PMID:32076005
NCBI chr17:40,818,117...40,822,614
Ensembl chr17:40,818,117...40,822,614
G
LORICRIN
loricrin cornified envelope precursor protein
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of LORICRIN mRNA
CTD
PMID:32076005
NCBI chr 1:153,259,687...153,262,124
Ensembl chr 1:153,259,687...153,262,124
G
MAOA
monoamine oxidase A
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of MAOA mRNA
CTD
PMID:32076005
NCBI chr X:43,655,006...43,746,817
Ensembl chr X:43,654,907...43,746,817
G
MAP2K1
mitogen-activated protein kinase kinase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of MAP2K1 mRNA
CTD
PMID:32076005
NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased phosphorylation of MAPK1 protein
CTD
PMID:32076005
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased phosphorylation of MAPK3 protein
CTD
PMID:32076005
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MGST1
microsomal glutathione S-transferase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of MGST1 mRNA
CTD
PMID:32076005
NCBI chr12:16,347,115...16,593,331
Ensembl chr12:16,347,142...16,609,259
G
MMP7
matrix metallopeptidase 7
increases expression multiple interactions
EXP
antimonite results in increased expression of MMP7 mRNA RTKI cpd inhibits the reaction [antimonite results in increased expression of MMP7 mRNA]
CTD
PMID:17400267
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
G
NFKB2
nuclear factor kappa B subunit 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of NFKB2 mRNA
CTD
PMID:32076005
NCBI chr10:102,394,110...102,402,529
Ensembl chr10:102,394,110...102,402,524
G
NQO1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of NQO1 mRNA
CTD
PMID:32076005
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
OSM
oncostatin M
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] inhibits the reaction [OSM protein results in increased phosphorylation of STAT1 protein]
CTD
PMID:32076005
NCBI chr22:30,262,829...30,266,851
Ensembl chr22:30,262,829...30,266,851
G
PBX1
PBX homeobox 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PBX1 mRNA
CTD
PMID:32076005
NCBI chr 1:164,559,184...164,886,047
Ensembl chr 1:164,555,584...164,899,296
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PIK3R1 mRNA
CTD
PMID:32076005
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,756...68,301,821
G
PIK3R2
phosphoinositide-3-kinase regulatory subunit 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PIK3R2 mRNA
CTD
PMID:32076005
NCBI chr19:18,153,163...18,170,532
Ensembl chr19:18,153,163...18,170,532
G
PIR
pirin
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of PIR mRNA
CTD
PMID:32076005
NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564
G
PITX1
paired like homeodomain 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PITX1 mRNA
CTD
PMID:32076005
NCBI chr 5:135,027,734...135,034,789
Ensembl chr 5:135,027,734...135,034,813
G
POLR2J2
RNA polymerase II subunit J2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of POLR2J2 mRNA
CTD
PMID:32076005
NCBI chr 7:102,666,046...102,671,663
Ensembl chr 7:102,665,368...102,671,629
G
PPARD
peroxisome proliferator activated receptor delta
increases expression multiple interactions
EXP
antimonite results in increased expression of PPARD mRNA RTKI cpd inhibits the reaction [antimonite results in increased expression of PPARD mRNA]
CTD
PMID:17400267
NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191
G
PRDX1
peroxiredoxin 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of PRDX1 mRNA
CTD
PMID:32076005
NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
G
SERPINE1
serpin family E member 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SERPINE1 mRNA
CTD
PMID:32076005
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SLC2A3
solute carrier family 2 member 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SLC2A3 mRNA
CTD
PMID:32076005
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...7,936,187
G
SOD1
superoxide dismutase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SOD1 mRNA
CTD
PMID:32076005
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SQSTM1
sequestosome 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SQSTM1 mRNA
CTD
PMID:32076005
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
STAT1
signal transducer and activator of transcription 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] inhibits the reaction [OSM protein results in increased phosphorylation of STAT1 protein]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of STAT1 mRNA
CTD
PMID:32076005
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
G
SULT1C3
sulfotransferase family 1C member 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT1C3 mRNA
CTD
PMID:32076005
NCBI chr 2:108,239,968...108,265,351
Ensembl chr 2:108,239,968...108,265,351
G
SULT1E1
sulfotransferase family 1E member 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT1E1 mRNA
CTD
PMID:32076005
NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145
G
SULT2B1
sulfotransferase family 2B member 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT2B1 mRNA
CTD
PMID:32076005
NCBI chr19:48,552,172...48,599,427
Ensembl chr19:48,552,172...48,599,425
G
TGM1
transglutaminase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TGM1 mRNA
CTD
PMID:32076005
NCBI chr14:24,249,114...24,263,177
Ensembl chr14:24,249,114...24,264,432
G
TP63
tumor protein p63
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TP63 mRNA
CTD
PMID:32076005
NCBI chr 3:189,596,746...189,897,276
Ensembl chr 3:189,631,389...189,897,276
G
TSC22D3
TSC22 domain family member 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TSC22D3 mRNA
CTD
PMID:32076005
NCBI chr X:107,713,221...107,777,086
Ensembl chr X:107,713,221...107,777,342
G
TXN
thioredoxin
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of TXN mRNA
CTD
PMID:32076005
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
TXNRD1
thioredoxin reductase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of TXNRD1 mRNA
CTD
PMID:32076005
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
UGT1A6
UDP glucuronosyltransferase family 1 member A6
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of UGT1A6 mRNA
CTD
PMID:32076005
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
G
CASP3
caspase 3
increases cleavage
EXP
antimony trichloride results in increased cleavage of CASP3 protein
CTD
PMID:30055241
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
G
DDB1
damage specific DNA binding protein 1
decreases expression
EXP
antimony trichloride results in decreased expression of DDB1 mRNA; antimony trichloride results in decreased expression of DDB1 protein
CTD
PMID:20509621
NCBI chr11:61,299,451...61,333,105
Ensembl chr11:61,299,451...61,342,596
G
MAPK1
mitogen-activated protein kinase 1
increases phosphorylation multiple interactions
EXP
antimony trichloride results in increased phosphorylation of MAPK1 protein Acetylcysteine inhibits the reaction [antimony trichloride results in increased phosphorylation of MAPK1 protein]
CTD
PMID:30055241
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
increases phosphorylation multiple interactions
EXP
antimony trichloride results in increased phosphorylation of MAPK3 protein Acetylcysteine inhibits the reaction [antimony trichloride results in increased phosphorylation of MAPK3 protein]
CTD
PMID:30055241
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
SIRT1
sirtuin 1
decreases expression multiple interactions
EXP
antimony trichloride results in decreased expression of SIRT1 mRNA; antimony trichloride results in decreased expression of SIRT1 protein Acetylcysteine inhibits the reaction [antimony trichloride results in decreased expression of SIRT1 mRNA]; Acetylcysteine inhibits the reaction [antimony trichloride results in decreased expression of SIRT1 protein]; Cycloheximide promotes the reaction [antimony trichloride results in decreased expression of SIRT1 protein]; Dactinomycin affects the reaction [antimony trichloride results in decreased expression of SIRT1 mRNA]; U 0126 inhibits the reaction [antimony trichloride results in decreased expression of SIRT1 protein]
CTD
PMID:30055241
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
G
XPA
XPA, DNA damage recognition and repair factor
multiple interactions affects binding
EXP
antimony trichloride inhibits the reaction [XPA protein binds to Zinc] antimony trichloride binds to XPA protein
CTD
PMID:20509621
NCBI chr 9:97,654,398...97,697,340
Ensembl chr 9:97,674,909...97,697,340
G
A2M
alpha-2-macroglobulin
decreases expression
EXP
Antimony results in decreased expression of A2M mRNA
CTD
PMID:17547211
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
G
ABCC1
ATP binding cassette subfamily C member 1
decreases response to substance multiple interactions
EXP
ABCC1 protein results in decreased susceptibility to Antimony; ABCC1 protein results in decreased susceptibility to Antimony analog GCLC protein inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony]
CTD
PMID:7954421 PMID:11560771
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
G
ACP2
acid phosphatase 2, lysosomal
decreases expression
EXP
Antimony results in decreased expression of ACP2 mRNA
CTD
PMID:17547211
NCBI chr11:47,239,302...47,248,814
Ensembl chr11:47,239,302...47,248,906
G
ACSL1
acyl-CoA synthetase long chain family member 1
decreases expression
EXP
Antimony results in decreased expression of ACSL1 mRNA
CTD
PMID:17547211
NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818
G
ADM
adrenomedullin
increases expression
EXP
Antimony results in increased expression of ADM mRNA
CTD
PMID:17547211
NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397
G
AKR1B1
aldo-keto reductase family 1 member B
decreases expression
EXP
Antimony results in decreased expression of AKR1B1 mRNA
CTD
PMID:17547211
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
G
ALDH6A1
aldehyde dehydrogenase 6 family member A1
decreases expression
EXP
Antimony results in decreased expression of ALDH6A1 mRNA
CTD
PMID:17547211
NCBI chr14:74,056,847...74,084,453
Ensembl chr14:74,056,847...74,084,492
G
AQP9
aquaporin 9
multiple interactions
EXP
AQP9 protein results in increased uptake of and results in increased susceptibility to Antimony
CTD
PMID:15336539
NCBI chr15:58,138,169...58,185,911
Ensembl chr15:58,138,169...58,185,911
G
ATP2B1
ATPase plasma membrane Ca2+ transporting 1
decreases expression
EXP
Antimony results in decreased expression of ATP2B1 mRNA
CTD
PMID:17547211
NCBI chr12:89,588,049...89,709,366
Ensembl chr12:89,588,049...89,709,300
G
AZGP1
alpha-2-glycoprotein 1, zinc-binding
decreases expression
EXP
Antimony results in decreased expression of AZGP1 mRNA
CTD
PMID:17547211
NCBI chr 7:99,966,730...99,976,031
Ensembl chr 7:99,966,720...99,976,042
G
BAX
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of BAX protein
CTD
PMID:32920012
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
multiple interactions
ISO
666-15 compound promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein
CTD
PMID:32920012
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
CASP3
caspase 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased cleavage of CASP3 protein
CTD
PMID:32920012
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
G
CCNB2
cyclin B2
increases expression
EXP
Antimony results in increased expression of CCNB2 mRNA
CTD
PMID:17547211
NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
G
CCND1
cyclin D1
multiple interactions
ISO
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]
CTD
PMID:34571074
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CDKN1A
cyclin dependent kinase inhibitor 1A
increases expression
EXP
Antimony results in increased expression of CDKN1A mRNA
CTD
PMID:17547211
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN3
cyclin dependent kinase inhibitor 3
increases expression
EXP
Antimony results in increased expression of CDKN3 mRNA
CTD
PMID:17547211
NCBI chr14:54,397,007...54,420,218
Ensembl chr14:54,396,849...54,420,218
G
CFB
complement factor B
decreases expression
EXP
Antimony results in decreased expression of CFB mRNA
CTD
PMID:17547211
NCBI chr 6:31,946,095...31,952,084
Ensembl chr 6:31,945,650...31,952,084
G
CKS2
CDC28 protein kinase regulatory subunit 2
increases expression
EXP
Antimony results in increased expression of CKS2 mRNA
CTD
PMID:17547211
NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
G
CLGN
calmegin
decreases expression
EXP
Antimony results in decreased expression of CLGN mRNA
CTD
PMID:17547211
NCBI chr 4:140,388,453...140,427,648
Ensembl chr 4:140,388,453...140,427,661
G
CLPTM1
CLPTM1 regulator of GABA type A receptor forward trafficking
decreases expression
EXP
Antimony results in decreased expression of CLPTM1 mRNA
CTD
PMID:17547211
NCBI chr19:44,954,585...44,993,341
Ensembl chr19:44,954,585...44,993,341
G
CREB1
cAMP responsive element binding protein 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein; pyrazolanthrone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]
CTD
PMID:32920012 PMID:34571074
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
DAZAP1
DAZ associated protein 1
increases expression
EXP
Antimony results in increased expression of DAZAP1 mRNA
CTD
PMID:17547211
NCBI chr19:1,407,586...1,435,684
Ensembl chr19:1,407,569...1,435,687
G
DCP1A
decapping mRNA 1A
increases expression
EXP
Antimony results in increased expression of DCP1A mRNA
CTD
PMID:17547211
NCBI chr 3:53,283,429...53,347,543
Ensembl chr 3:53,283,429...53,347,586
G
DUSP1
dual specificity phosphatase 1
increases expression
EXP
Antimony results in increased expression of DUSP1 mRNA
CTD
PMID:17547211
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
F5
coagulation factor V
decreases expression
EXP
Antimony results in decreased expression of F5 mRNA
CTD
PMID:17547211
NCBI chr 1:169,511,951...169,586,481
Ensembl chr 1:169,511,951...169,586,588
G
FDFT1
farnesyl-diphosphate farnesyltransferase 1
decreases expression
EXP
Antimony results in decreased expression of FDFT1 mRNA
CTD
PMID:17547211
NCBI chr 8:11,795,582...11,839,309
Ensembl chr 8:11,795,573...11,839,304
G
FDPS
farnesyl diphosphate synthase
decreases expression
EXP
Antimony results in decreased expression of FDPS mRNA
CTD
PMID:17547211
NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666
G
FOSL1
FOS like 1, AP-1 transcription factor subunit
increases expression
EXP
Antimony results in increased expression of FOSL1 mRNA
CTD
PMID:17547211
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
G
GCLC
glutamate-cysteine ligase catalytic subunit
multiple interactions
EXP
GCLC protein inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony]
CTD
PMID:11560771
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCNT3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
EXP
Antimony results in increased expression of GCNT3 mRNA
CTD
PMID:17547211
NCBI chr15:59,549,039...59,622,723
Ensembl chr15:59,594,875...59,640,239
G
GFAP
glial fibrillary acidic protein
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein 666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA]
CTD
PMID:34571074
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
G
GHITM
growth hormone inducible transmembrane protein
decreases expression
EXP
Antimony results in decreased expression of GHITM mRNA
CTD
PMID:17547211
NCBI chr10:84,139,509...84,153,568
Ensembl chr10:84,139,482...84,154,841
G
GLA
galactosidase alpha
increases expression
EXP
Antimony results in increased expression of GLA mRNA
CTD
PMID:17547211
NCBI chr X:101,397,803...101,407,925
Ensembl chr X:101,393,273...101,408,012
G
GTPBP6
GTP binding protein 6 (putative)
increases expression
EXP
Antimony results in increased expression of GTPBP6 mRNA
CTD
PMID:17547211
NCBI chr X:304,759...318,796 NCBI chr Y:304,759...318,796
Ensembl chr X:304,529...318,819
G
H4C3
H4 clustered histone 3
increases expression
EXP
Antimony results in increased expression of H4C3 mRNA
CTD
PMID:17547211
NCBI chr 6:26,103,933...26,104,337
Ensembl chr 6:26,103,933...26,104,337
G
HMGA1
high mobility group AT-hook 1
increases expression
EXP
Antimony results in increased expression of HMGA1 mRNA
CTD
PMID:17547211
NCBI chr 6:34,236,873...34,246,231
Ensembl chr 6:34,236,873...34,246,231
G
HMOX1
heme oxygenase 1
increases expression
EXP
Antimony results in increased expression of HMOX1 mRNA
CTD
PMID:17547211
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HSD17B2
hydroxysteroid 17-beta dehydrogenase 2
decreases expression
EXP
Antimony results in decreased expression of HSD17B2 mRNA
CTD
PMID:17547211
NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,035,004...82,098,534
G
HSD17B7
hydroxysteroid 17-beta dehydrogenase 7
decreases expression
EXP
Antimony results in decreased expression of HSD17B7 mRNA
CTD
PMID:17547211
NCBI chr 1:162,790,702...162,812,823
Ensembl chr 1:162,790,702...162,812,823
G
IER2
immediate early response 2
increases expression
EXP
Antimony results in increased expression of IER2 mRNA
CTD
PMID:17547211
NCBI chr19:13,150,411...13,154,911
Ensembl chr19:13,150,411...13,154,911
G
IFNG
interferon gamma
affects response to substance
ISO
IFNG protein affects the susceptibility to Antimony
CTD
PMID:11035738
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IFRD1
interferon related developmental regulator 1
decreases expression
EXP
Antimony results in decreased expression of IFRD1 mRNA
CTD
PMID:17547211
NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017
G
IL12A
interleukin 12A
affects response to substance
ISO
IL12A protein affects the susceptibility to Antimony
CTD
PMID:11023473
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
G
IL12B
interleukin 12B
affects response to substance
ISO
IL12B protein affects the susceptibility to Antimony
CTD
PMID:11023473
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
G
ING3
inhibitor of growth family member 3
increases expression
EXP
Antimony results in increased expression of ING3 mRNA
CTD
PMID:17547211
NCBI chr 7:120,950,777...120,977,216
Ensembl chr 7:120,950,763...120,977,216
G
ITGB3BP
integrin subunit beta 3 binding protein
increases expression
EXP
Antimony results in increased expression of ITGB3BP mRNA
CTD
PMID:17547211
NCBI chr 1:63,440,770...63,529,187
Ensembl chr 1:63,440,770...63,593,721
G
ITIH3
inter-alpha-trypsin inhibitor heavy chain 3
decreases expression
EXP
Antimony results in decreased expression of ITIH3 mRNA
CTD
PMID:17547211
NCBI chr 3:52,794,796...52,808,797
Ensembl chr 3:52,794,768...52,809,009
G
KLF6
Kruppel like factor 6
increases expression
EXP
Antimony results in increased expression of KLF6 mRNA
CTD
PMID:17547211
NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281
G
LIPA
lipase A, lysosomal acid type
decreases expression
EXP
Antimony results in decreased expression of LIPA mRNA
CTD
PMID:17547211
NCBI chr10:89,213,572...89,251,775
Ensembl chr10:89,213,569...89,414,557
G
LSS
lanosterol synthase
decreases expression
EXP
Antimony results in decreased expression of LSS mRNA
CTD
PMID:17547211
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
G
MAFF
MAF bZIP transcription factor F
increases expression
EXP
Antimony results in increased expression of MAFF mRNA
CTD
PMID:17547211
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
G
MAN1A2
mannosidase alpha class 1A member 2
decreases expression
EXP
Antimony results in decreased expression of MAN1A2 mRNA
CTD
PMID:17547211
NCBI chr 1:117,367,449...117,528,872
Ensembl chr 1:117,367,449...117,528,872
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of MAPK1 protein
CTD
PMID:32920012 PMID:34571074
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of MAPK3 protein
CTD
PMID:32920012 PMID:34571074
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MCM2
minichromosome maintenance complex component 2
increases expression
EXP
Antimony results in increased expression of MCM2 mRNA
CTD
PMID:17547211
NCBI chr 3:127,598,411...127,622,436
Ensembl chr 3:127,598,410...127,622,436
G
MGAT2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
decreases expression
EXP
Antimony results in decreased expression of MGAT2 mRNA
CTD
PMID:17547211
NCBI chr14:49,620,799...49,623,481
Ensembl chr14:49,620,799...49,623,481
G
MIR196B
microRNA 196b
multiple interactions
EXP
[Air Pollutants, Occupational results in increased abundance of Antimony] which results in increased expression of MIR196B mRNA
CTD
PMID:27506416
NCBI chr 7:27,169,480...27,169,563
Ensembl chr 7:27,169,480...27,169,563
G
MT1X
metallothionein 1X
decreases expression
EXP
Antimony results in decreased expression of MT1X mRNA
CTD
PMID:17547211
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
G
NDRG2
NDRG family member 2
decreases expression
EXP
Antimony results in decreased expression of NDRG2 mRNA
CTD
PMID:17547211
NCBI chr14:21,016,763...21,070,872
Ensembl chr14:21,016,763...21,070,872
G
NFKBIA
NFKB inhibitor alpha
decreases expression
EXP
Antimony results in decreased expression of NFKBIA mRNA
CTD
PMID:17547211
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,513...35,404,749
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 mRNA]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein]
CTD
PMID:34571074
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NR0B2
nuclear receptor subfamily 0 group B member 2
decreases expression
EXP
Antimony results in decreased expression of NR0B2 mRNA
CTD
PMID:17547211
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
OS9
OS9 endoplasmic reticulum lectin
decreases expression
EXP
Antimony results in decreased expression of OS9 mRNA
CTD
PMID:17547211
NCBI chr12:57,694,132...57,721,557
Ensembl chr12:57,693,955...57,721,557
G
PCNA
proliferating cell nuclear antigen
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of PCNA protein
CTD
PMID:34571074
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
PDIA4
protein disulfide isomerase family A member 4
decreases expression
EXP
Antimony results in decreased expression of PDIA4 mRNA
CTD
PMID:17547211
NCBI chr 7:149,003,051...149,028,505
Ensembl chr 7:149,003,062...149,028,662
G
PGC
progastricsin
decreases expression
EXP
Antimony results in decreased expression of PGC mRNA
CTD
PMID:17547211
NCBI chr 6:41,736,711...41,747,397
Ensembl chr 6:41,736,711...41,754,109
G
PML
PML nuclear body scaffold
multiple interactions
EXP
Antimony affects the localization of and results in increased sumoylation of PML protein
CTD
PMID:26049103
NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827
G
PPIH
peptidylprolyl isomerase H
increases expression
EXP
Antimony results in increased expression of PPIH mRNA
CTD
PMID:17547211
NCBI chr 1:42,658,423...42,681,654
Ensembl chr 1:42,658,335...42,676,758
G
PSPH
phosphoserine phosphatase
decreases expression
EXP
Antimony results in decreased expression of PSPH mRNA
CTD
PMID:17547211
NCBI chr 7:56,011,064...56,051,444
Ensembl chr 7:56,011,051...56,051,604
G
PTTG1
PTTG1 regulator of sister chromatid separation, securin
increases expression
EXP
Antimony results in increased expression of PTTG1 mRNA
CTD
PMID:17547211
NCBI chr 5:160,421,855...160,428,744
Ensembl chr 5:160,421,855...160,428,739
G
RBPMS
RNA binding protein, mRNA processing factor
increases expression
EXP
Antimony results in increased expression of RBPMS mRNA
CTD
PMID:17547211
NCBI chr 8:30,384,541...30,572,256
Ensembl chr 8:30,384,511...30,572,256
G
RFC2
replication factor C subunit 2
increases expression
EXP
Antimony results in increased expression of RFC2 mRNA
CTD
PMID:17547211
NCBI chr 7:74,231,502...74,254,399
Ensembl chr 7:74,231,499...74,254,458
G
RNASEH2A
ribonuclease H2 subunit A
increases expression
EXP
Antimony results in increased expression of RNASEH2A mRNA
CTD
PMID:17547211
NCBI chr19:12,806,584...12,813,640
Ensembl chr19:12,806,584...12,813,640
G
SCD
stearoyl-CoA desaturase
decreases expression
EXP
Antimony results in decreased expression of SCD mRNA
CTD
PMID:17547211
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
G
SEPHS2
selenophosphate synthetase 2
decreases expression
EXP
Antimony results in decreased expression of SEPHS2 mRNA
CTD
PMID:17547211
NCBI chr16:30,443,631...30,445,874
Ensembl chr16:30,443,631...30,445,874
G
SERPINB1
serpin family B member 1
decreases expression
EXP
Antimony results in decreased expression of SERPINB1 mRNA
CTD
PMID:17547211
NCBI chr 6:2,832,332...2,841,863
Ensembl chr 6:2,832,332...2,841,959
G
SERPINC1
serpin family C member 1
decreases expression
EXP
Antimony results in decreased expression of SERPINC1 mRNA
CTD
PMID:17547211
NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327
G
SIK1
salt inducible kinase 1
increases expression
EXP
Antimony results in increased expression of SIK1 mRNA
CTD
PMID:17547211
NCBI chr21:43,414,483...43,427,131
Ensembl chr21:43,414,483...43,427,131
G
SNRPA
small nuclear ribonucleoprotein polypeptide A
increases expression
EXP
Antimony results in increased expression of SNRPA mRNA
CTD
PMID:17547211
NCBI chr19:40,751,203...40,765,389
Ensembl chr19:40,750,637...40,765,389
G
SQLE
squalene epoxidase
decreases expression
EXP
Antimony results in decreased expression of SQLE mRNA
CTD
PMID:17547211
NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283
G
SRSF1
serine and arginine rich splicing factor 1
decreases expression
EXP
Antimony results in decreased expression of SRSF1 mRNA
CTD
PMID:17547211
NCBI chr17:57,989,038...58,007,246
Ensembl chr17:58,000,919...58,007,346
G
SRSF5
serine and arginine rich splicing factor 5
decreases expression
EXP
Antimony results in decreased expression of SRSF5 mRNA
CTD
PMID:17547211
NCBI chr14:69,767,142...69,772,005
Ensembl chr14:69,726,900...69,772,005
G
ST6GALNAC4
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4
decreases expression
EXP
Antimony results in decreased expression of ST6GALNAC4 mRNA
CTD
PMID:17547211
NCBI chr 9:127,907,886...127,917,041
Ensembl chr 9:127,907,886...127,917,041
G
TARDBP
TAR DNA binding protein
decreases expression
EXP
Antimony results in decreased expression of TARDBP mRNA
CTD
PMID:17547211
NCBI chr 1:11,012,654...11,030,528
Ensembl chr 1:11,012,344...11,030,528
G
TNFAIP3
TNF alpha induced protein 3
increases expression
EXP
Antimony results in increased expression of TNFAIP3 mRNA
CTD
PMID:17547211
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,312
G
TNFSF10
TNF superfamily member 10
decreases expression
EXP
Antimony results in decreased expression of TNFSF10 mRNA
CTD
PMID:17547211
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
G
TOB1
transducer of ERBB2, 1
decreases expression
EXP
Antimony results in decreased expression of TOB1 mRNA
CTD
PMID:17547211
NCBI chr17:50,862,223...50,867,978
Ensembl chr17:50,862,223...50,867,978
G
TSPAN7
tetraspanin 7
decreases expression
EXP
Antimony results in decreased expression of TSPAN7 mRNA
CTD
PMID:17547211
NCBI chr X:38,561,542...38,688,918
Ensembl chr X:38,561,542...38,688,920
G
TUFT1
tuftelin 1
increases expression
EXP
Antimony results in increased expression of TUFT1 mRNA
CTD
PMID:17547211
NCBI chr 1:151,540,309...151,583,583
Ensembl chr 1:151,540,305...151,583,583
G
TXNRD1
thioredoxin reductase 1
increases expression
EXP
Antimony results in increased expression of TXNRD1 mRNA
CTD
PMID:17547211
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
TYMS
thymidylate synthetase
increases expression
EXP
Antimony results in increased expression of TYMS mRNA
CTD
PMID:17547211
NCBI chr18:657,653...673,578
Ensembl chr18:657,653...673,578
G
UBE2C
ubiquitin conjugating enzyme E2 C
increases expression
EXP
Antimony results in increased expression of UBE2C mRNA
CTD
PMID:17547211
NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957
G
ZWINT
ZW10 interacting kinetochore protein
increases expression
EXP
Antimony results in increased expression of ZWINT mRNA
CTD
PMID:17547211
NCBI chr10:56,357,227...56,361,273
Ensembl chr10:56,357,227...56,361,273
G
A2M
alpha-2-macroglobulin
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of A2M mRNA
CTD
PMID:17547211
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
G
ABCC1
ATP binding cassette subfamily C member 1
affects response to substance decreases response to substance increases secretion multiple interactions
EXP
ABCC1 protein affects the susceptibility to Antimony Potassium Tartrate ABCC1 protein results in decreased susceptibility to Antimony Potassium Tartrate ABCC1 protein results in increased secretion of Antimony Potassium Tartrate [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Antimony Potassium Tartrate; Glutathione affects the reaction [ABCC1 protein results in increased secretion of Antimony Potassium Tartrate]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony Potassium Tartrate]; verlukast inhibits the reaction [ABCC1 protein results in increased secretion of Antimony Potassium Tartrate]
CTD
PMID:10025956 PMID:10348353 PMID:11278867 PMID:12018890 PMID:12731862
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
G
ABCC2
ATP binding cassette subfamily C member 2
increases expression multiple interactions
ISO EXP
Antimony Potassium Tartrate results in increased expression of ABCC2 mRNA; Antimony Potassium Tartrate results in increased expression of ABCC2 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ABCC2 mRNA
CTD
PMID:11408547 PMID:32076005
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCC3
ATP binding cassette subfamily C member 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ABCC3 mRNA
CTD
PMID:32076005
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
G
ACP2
acid phosphatase 2, lysosomal
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of ACP2 mRNA
CTD
PMID:17547211
NCBI chr11:47,239,302...47,248,814
Ensembl chr11:47,239,302...47,248,906
G
ACSL1
acyl-CoA synthetase long chain family member 1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of ACSL1 mRNA
CTD
PMID:17547211
NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818
G
ADM
adrenomedullin
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of ADM mRNA
CTD
PMID:17547211
NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397
G
AKR1B1
aldo-keto reductase family 1 member B
decreases expression increases expression
EXP
Antimony Potassium Tartrate results in decreased expression of AKR1B1 mRNA Antimony Potassium Tartrate results in increased expression of AKR1B1 mRNA
CTD
PMID:17547211 PMID:28713220
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
G
AKR1B10
aldo-keto reductase family 1 member B10
increases expression multiple interactions
EXP
Antimony Potassium Tartrate results in increased expression of AKR1B10 mRNA [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1B10 mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
G
AKR1C2
aldo-keto reductase family 1 member C2
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of AKR1C2 protein
CTD
PMID:28713220
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
G
AKR1C3
aldo-keto reductase family 1 member C3
increases expression multiple interactions
EXP
Antimony Potassium Tartrate results in increased expression of AKR1C3 mRNA; Antimony Potassium Tartrate results in increased expression of AKR1C3 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1C3 mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
G
ALDH3A2
aldehyde dehydrogenase 3 family member A2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ALDH3A2 mRNA
CTD
PMID:32076005
NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760
G
ALDH3B2
aldehyde dehydrogenase 3 family member B2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ALDH3B2 mRNA
CTD
PMID:32076005
NCBI chr11:67,662,155...67,681,252
Ensembl chr11:67,662,155...67,681,224
G
ALDH6A1
aldehyde dehydrogenase 6 family member A1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of ALDH6A1 mRNA
CTD
PMID:17547211
NCBI chr14:74,056,847...74,084,453
Ensembl chr14:74,056,847...74,084,492
G
ALDOA
aldolase, fructose-bisphosphate A
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of ALDOA mRNA
CTD
PMID:28713220
NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457
G
ALDOC
aldolase, fructose-bisphosphate C
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of ALDOC mRNA
CTD
PMID:28713220
NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948
G
AR
androgen receptor
increases phosphorylation
EXP
Antimony Potassium Tartrate results in increased phosphorylation of AR protein
CTD
PMID:29462692
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
ATP2B1
ATPase plasma membrane Ca2+ transporting 1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of ATP2B1 mRNA
CTD
PMID:17547211
NCBI chr12:89,588,049...89,709,366
Ensembl chr12:89,588,049...89,709,300
G
AZGP1
alpha-2-glycoprotein 1, zinc-binding
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of AZGP1 mRNA
CTD
PMID:17547211
NCBI chr 7:99,966,730...99,976,031
Ensembl chr 7:99,966,720...99,976,042
G
BARX2
BARX homeobox 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BARX2 mRNA
CTD
PMID:32076005
NCBI chr11:129,375,233...129,452,279
Ensembl chr11:129,375,848...129,452,279
G
BAX
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of BAX protein
CTD
PMID:32920012
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein 666-15 compound promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein
CTD
PMID:32920012
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BMP6
bone morphogenetic protein 6
multiple interactions
EXP
Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP12 mRNA]; Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP2 mRNA]
CTD
PMID:28713220
NCBI chr 6:7,726,099...7,881,728
Ensembl chr 6:7,726,099...7,881,728
G
BTF3
basic transcription factor 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTF3 mRNA
CTD
PMID:32076005
NCBI chr 5:73,498,442...73,505,667
Ensembl chr 5:73,498,408...73,505,667
G
BTG2
BTG anti-proliferation factor 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTG2 mRNA
CTD
PMID:32076005
NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
G
CALML5
calmodulin like 5
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of CALML5 mRNA
CTD
PMID:28713220
NCBI chr10:5,498,697...5,499,570
Ensembl chr10:5,498,697...5,499,570
G
CALR
calreticulin
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CALR mRNA
CTD
PMID:32076005
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
G
CASP3
caspase 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased cleavage of CASP3 protein
CTD
PMID:32920012
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
G
CBR1
carbonyl reductase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA
CTD
PMID:32076005
NCBI chr21:36,070,024...36,073,164
Ensembl chr21:36,069,941...36,073,166
G
CCNB2
cyclin B2
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of CCNB2 mRNA
CTD
PMID:17547211
NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
G
CCND1
cyclin D1
multiple interactions
ISO
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]
CTD
PMID:34571074
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CDKN1A
cyclin dependent kinase inhibitor 1A
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of CDKN1A mRNA
CTD
PMID:17547211
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN2B
cyclin dependent kinase inhibitor 2B
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CDKN2B mRNA
CTD
PMID:32076005
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
G
CDKN3
cyclin dependent kinase inhibitor 3
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of CDKN3 mRNA
CTD
PMID:17547211
NCBI chr14:54,397,007...54,420,218
Ensembl chr14:54,396,849...54,420,218
G
CEBPA
CCAAT enhancer binding protein alpha
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CEBPA mRNA
CTD
PMID:32076005
NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
G
CFB
complement factor B
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of CFB mRNA
CTD
PMID:17547211
NCBI chr 6:31,946,095...31,952,084
Ensembl chr 6:31,945,650...31,952,084
G
CKS2
CDC28 protein kinase regulatory subunit 2
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of CKS2 mRNA
CTD
PMID:17547211
NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
G
CLGN
calmegin
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of CLGN mRNA
CTD
PMID:17547211
NCBI chr 4:140,388,453...140,427,648
Ensembl chr 4:140,388,453...140,427,661
G
CLPTM1
CLPTM1 regulator of GABA type A receptor forward trafficking
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of CLPTM1 mRNA
CTD
PMID:17547211
NCBI chr19:44,954,585...44,993,341
Ensembl chr19:44,954,585...44,993,341
G
CNBP
CCHC-type zinc finger nucleic acid binding protein
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CNBP mRNA
CTD
PMID:32076005
NCBI chr 3:129,167,827...129,183,896
Ensembl chr 3:129,167,827...129,183,922
G
CREB1
cAMP responsive element binding protein 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein; pyrazolanthrone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]
CTD
PMID:32920012 PMID:34571074
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CST2
cystatin SA
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of CST2 mRNA
CTD
PMID:28713220
NCBI chr20:23,823,769...23,826,729
Ensembl chr20:23,823,769...23,826,729
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CYP1B1 mRNA
CTD
PMID:32076005
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
DAZAP1
DAZ associated protein 1
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of DAZAP1 mRNA
CTD
PMID:17547211
NCBI chr19:1,407,586...1,435,684
Ensembl chr19:1,407,569...1,435,687
G
DCP1A
decapping mRNA 1A
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of DCP1A mRNA
CTD
PMID:17547211
NCBI chr 3:53,283,429...53,347,543
Ensembl chr 3:53,283,429...53,347,586
G
DHRS9
dehydrogenase/reductase 9
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DHRS9 mRNA
CTD
PMID:32076005
NCBI chr 2:169,067,077...169,096,167
Ensembl chr 2:169,064,789...169,096,167
G
DNAJB1
DnaJ heat shock protein family (Hsp40) member B1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DNAJB1 mRNA
CTD
PMID:32076005
NCBI chr19:14,514,769...14,560,391
Ensembl chr19:14,514,769...14,560,391
G
DNAJB4
DnaJ heat shock protein family (Hsp40) member B4
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of DNAJB4 mRNA
CTD
PMID:32076005
NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
G
DSC1
desmocollin 1
decreases expression multiple interactions
EXP
Antimony Potassium Tartrate results in decreased expression of DSC1 mRNA [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSC1 mRNA; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSC1 mRNA]
CTD
PMID:28713220 PMID:32076005
NCBI chr18:31,129,236...31,162,856
Ensembl chr18:31,129,236...31,162,856
G
DSG1
desmoglein 1
multiple interactions
EXP
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]
CTD
PMID:32076005
NCBI chr18:31,318,160...31,359,246
Ensembl chr18:31,318,160...31,359,246
G
DST
dystonin
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of DST protein
CTD
PMID:28713220
NCBI chr 6:56,457,996...56,954,830
Ensembl chr 6:56,457,987...56,954,830
G
DUOX1
dual oxidase 1
decreases expression multiple interactions
EXP
Antimony Potassium Tartrate results in decreased expression of DUOX1 mRNA Antimony Potassium Tartrate inhibits the reaction [IL4 protein results in increased expression of DUOX1 mRNA]
CTD
PMID:29031483
NCBI chr15:45,129,994...45,165,574
Ensembl chr15:45,129,933...45,165,576
G
DUOXA1
dual oxidase maturation factor 1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of DUOXA1 mRNA
CTD
PMID:29031483
NCBI chr15:45,117,366...45,129,879
Ensembl chr15:45,117,366...45,129,938
G
DUSP1
dual specificity phosphatase 1
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of DUSP1 mRNA
CTD
PMID:17547211
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
DUSP12
dual specificity phosphatase 12
multiple interactions
EXP
Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP12 mRNA]
CTD
PMID:28713220
NCBI chr 1:161,749,786...161,757,238
Ensembl chr 1:161,749,758...161,757,238
G
DUSP2
dual specificity phosphatase 2
multiple interactions
EXP
Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP2 mRNA]
CTD
PMID:28713220
NCBI chr 2:96,143,169...96,145,440
Ensembl chr 2:96,143,169...96,145,440
G
EGR3
early growth response 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EGR3 mRNA
CTD
PMID:32076005
NCBI chr 8:22,687,659...22,693,480
Ensembl chr 8:22,687,659...22,693,480
G
EHF
ETS homologous factor
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EHF mRNA
CTD
PMID:32076005
NCBI chr11:34,621,093...34,663,288
Ensembl chr11:34,621,093...34,663,288
G
ELF3
E74 like ETS transcription factor 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ELF3 mRNA
CTD
PMID:32076005
NCBI chr 1:202,010,587...202,017,183
Ensembl chr 1:202,007,945...202,017,183
G
EPHA1
EPH receptor A1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA1 protein
CTD
PMID:32076005
NCBI chr 7:143,391,129...143,408,856
Ensembl chr 7:143,390,289...143,408,856
G
EPHA2
EPH receptor A2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA2 protein
CTD
PMID:32076005
NCBI chr 1:16,124,337...16,156,069
Ensembl chr 1:16,124,337...16,156,069
G
EPHX1
epoxide hydrolase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of EPHX1 mRNA
CTD
PMID:32076005
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
F5
coagulation factor V
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of F5 mRNA
CTD
PMID:17547211
NCBI chr 1:169,511,951...169,586,481
Ensembl chr 1:169,511,951...169,586,588
G
FABP5
fatty acid binding protein 5
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of FABP5 mRNA
CTD
PMID:28713220
NCBI chr 8:81,280,536...81,284,775
Ensembl chr 8:81,280,536...81,284,777
G
FDFT1
farnesyl-diphosphate farnesyltransferase 1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of FDFT1 mRNA
CTD
PMID:17547211
NCBI chr 8:11,795,582...11,839,309
Ensembl chr 8:11,795,573...11,839,304
G
FDPS
farnesyl diphosphate synthase
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of FDPS mRNA
CTD
PMID:17547211
NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666
G
FGFR3
fibroblast growth factor receptor 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FGFR3 mRNA
CTD
PMID:32076005
NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872
G
FLG
filaggrin
decreases expression multiple interactions
EXP
Antimony Potassium Tartrate results in decreased expression of FLG mRNA 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]
CTD
PMID:28713220 PMID:32076005
NCBI chr 1:152,302,165...152,325,239
Ensembl chr 1:152,302,165...152,325,239
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FOS mRNA
CTD
PMID:32076005
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FOSL1
FOS like 1, AP-1 transcription factor subunit
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of FOSL1 mRNA
CTD
PMID:17547211
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
G
FOXQ1
forkhead box Q1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FOXQ1 mRNA
CTD
PMID:32076005
NCBI chr 6:1,312,098...1,314,758
Ensembl chr 6:1,312,098...1,314,758
G
FTH1
ferritin heavy chain 1
increases expression multiple interactions
EXP
Antimony Potassium Tartrate results in increased expression of FTH1 mRNA; Antimony Potassium Tartrate results in increased expression of FTH1 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of FTH1 mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
G
FTL
ferritin light chain
increases expression multiple interactions
EXP
Antimony Potassium Tartrate results in increased expression of FTL mRNA [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of FTL mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
G
G6PD
glucose-6-phosphate dehydrogenase
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of G6PD mRNA; Antimony Potassium Tartrate results in increased expression of G6PD protein
CTD
PMID:28713220
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of GAPDH mRNA
CTD
PMID:28713220
NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
G
GCLC
glutamate-cysteine ligase catalytic subunit
increases expression multiple interactions
EXP
Antimony Potassium Tartrate results in increased expression of GCLC mRNA; Antimony Potassium Tartrate results in increased expression of GCLC protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLC mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression multiple interactions
EXP
Antimony Potassium Tartrate results in increased expression of GCLM mRNA [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLM mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GCNT3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of GCNT3 mRNA
CTD
PMID:17547211
NCBI chr15:59,549,039...59,622,723
Ensembl chr15:59,594,875...59,640,239
G
GFAP
glial fibrillary acidic protein
multiple interactions
ISO
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA]
CTD
PMID:34571074
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
G
GGT1
gamma-glutamyltransferase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GGT1 mRNA
CTD
PMID:32076005
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
G
GHITM
growth hormone inducible transmembrane protein
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of GHITM mRNA
CTD
PMID:17547211
NCBI chr10:84,139,509...84,153,568
Ensembl chr10:84,139,482...84,154,841
G
GLA
galactosidase alpha
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of GLA mRNA
CTD
PMID:17547211
NCBI chr X:101,397,803...101,407,925
Ensembl chr X:101,393,273...101,408,012
G
GLRX
glutaredoxin
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GLRX mRNA
CTD
PMID:32076005
NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
G
GPX2
glutathione peroxidase 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GPX2 mRNA
CTD
PMID:32076005
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
GRHL1
grainyhead like transcription factor 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of GRHL1 mRNA
CTD
PMID:32076005
NCBI chr 2:9,951,693...10,002,277
Ensembl chr 2:9,951,693...10,002,277
G
GSTO1
glutathione S-transferase omega 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GSTO1 mRNA
CTD
PMID:32076005
NCBI chr10:104,254,173...104,267,455
Ensembl chr10:104,235,356...104,267,459
G
GTPBP6
GTP binding protein 6 (putative)
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of GTPBP6 mRNA
CTD
PMID:17547211
NCBI chr X:304,759...318,796 NCBI chr Y:304,759...318,796
Ensembl chr X:304,529...318,819
G
H4C3
H4 clustered histone 3
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of H4C3 mRNA
CTD
PMID:17547211
NCBI chr 6:26,103,933...26,104,337
Ensembl chr 6:26,103,933...26,104,337
G
HLTF
helicase like transcription factor
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HLTF mRNA
CTD
PMID:32076005
NCBI chr 3:149,030,063...149,086,533
Ensembl chr 3:149,030,127...149,086,554
G
HMGA1
high mobility group AT-hook 1
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of HMGA1 mRNA
CTD
PMID:17547211
NCBI chr 6:34,236,873...34,246,231
Ensembl chr 6:34,236,873...34,246,231
G
HMOX1
heme oxygenase 1
increases expression multiple interactions
EXP
Antimony Potassium Tartrate results in increased expression of HMOX1 mRNA; Antimony Potassium Tartrate results in increased expression of HMOX1 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HMOX1 mRNA
CTD
PMID:17547211 PMID:28713220 PMID:32076005
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HOPX
HOP homeobox
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of HOPX mRNA
CTD
PMID:32076005
NCBI chr 4:56,647,998...56,681,706
Ensembl chr 4:56,647,988...56,681,899
G
HSD17B2
hydroxysteroid 17-beta dehydrogenase 2
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of HSD17B2 mRNA
CTD
PMID:17547211
NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,035,004...82,098,534
G
HSD17B7
hydroxysteroid 17-beta dehydrogenase 7
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of HSD17B7 mRNA
CTD
PMID:17547211
NCBI chr 1:162,790,702...162,812,823
Ensembl chr 1:162,790,702...162,812,823
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPA1A mRNA
CTD
PMID:32076005
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
HSPA8
heat shock protein family A (Hsp70) member 8
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPA8 mRNA
CTD
PMID:32076005
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
HSPB8
heat shock protein family B (small) member 8
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPB8 mRNA
CTD
PMID:32076005
NCBI chr12:119,178,931...119,194,746
Ensembl chr12:119,171,555...119,224,855
G
HTATIP2
HIV-1 Tat interactive protein 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HTATIP2 mRNA
CTD
PMID:32076005
NCBI chr11:20,363,714...20,383,782
Ensembl chr11:20,363,685...20,383,782
G
ID1
inhibitor of DNA binding 1, HLH protein
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ID1 mRNA
CTD
PMID:32076005
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
G
IER2
immediate early response 2
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of IER2 mRNA
CTD
PMID:17547211
NCBI chr19:13,150,411...13,154,911
Ensembl chr19:13,150,411...13,154,911
G
IFRD1
interferon related developmental regulator 1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of IFRD1 mRNA
CTD
PMID:17547211
NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017
G
IKZF2
IKAROS family zinc finger 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IKZF2 mRNA
CTD
PMID:32076005
NCBI chr 2:212,999,698...213,152,456
Ensembl chr 2:212,999,691...213,152,427
G
IL1RN
interleukin 1 receptor antagonist
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IL1RN mRNA
CTD
PMID:32076005
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL4
interleukin 4
multiple interactions
EXP
Antimony Potassium Tartrate inhibits the reaction [IL4 protein results in increased expression of DUOX1 mRNA]
CTD
PMID:29031483
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
ING3
inhibitor of growth family member 3
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of ING3 mRNA
CTD
PMID:17547211
NCBI chr 7:120,950,777...120,977,216
Ensembl chr 7:120,950,763...120,977,216
G
ITGB3BP
integrin subunit beta 3 binding protein
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of ITGB3BP mRNA
CTD
PMID:17547211
NCBI chr 1:63,440,770...63,529,187
Ensembl chr 1:63,440,770...63,593,721
G
ITIH3
inter-alpha-trypsin inhibitor heavy chain 3
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of ITIH3 mRNA
CTD
PMID:17547211
NCBI chr 3:52,794,796...52,808,797
Ensembl chr 3:52,794,768...52,809,009
G
IVL
involucrin
decreases expression multiple interactions
EXP
Antimony Potassium Tartrate results in decreased expression of IVL mRNA; Antimony Potassium Tartrate results in decreased expression of IVL protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IVL mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr 1:152,908,546...152,911,886
Ensembl chr 1:152,908,546...152,911,886
G
KLF5
Kruppel like factor 5
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KLF5 mRNA
CTD
PMID:32076005
NCBI chr13:73,054,976...73,077,538
Ensembl chr13:73,054,976...73,077,541
G
KLF6
Kruppel like factor 6
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of KLF6 mRNA
CTD
PMID:17547211
NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281
G
KLK3
kallikrein related peptidase 3
increases expression multiple interactions
EXP
Antimony Potassium Tartrate results in increased expression of KLK3 mRNA; Antimony Potassium Tartrate results in increased expression of KLK3 protein bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of KLK3 mRNA]
CTD
PMID:29462692
NCBI chr19:50,854,915...50,860,764
Ensembl chr19:50,854,915...50,860,764
G
KRT1
keratin 1
multiple interactions
EXP
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]
CTD
PMID:32076005
NCBI chr12:52,674,736...52,680,407
Ensembl chr12:52,674,736...52,680,407
G
KRT10
keratin 10
decreases expression multiple interactions
EXP
Antimony Potassium Tartrate results in decreased expression of KRT10 mRNA; Antimony Potassium Tartrate results in decreased expression of KRT10 protein 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]
CTD
PMID:28713220 PMID:32076005
NCBI chr17:40,818,117...40,822,614
Ensembl chr17:40,818,117...40,822,614
G
KRTDAP
keratinocyte differentiation associated protein
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of KRTDAP mRNA
CTD
PMID:28713220
NCBI chr19:35,487,324...35,490,464
Ensembl chr19:35,487,324...35,495,558
G
LIPA
lipase A, lysosomal acid type
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of LIPA mRNA
CTD
PMID:17547211
NCBI chr10:89,213,572...89,251,775
Ensembl chr10:89,213,569...89,414,557
G
LORICRIN
loricrin cornified envelope precursor protein
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of LORICRIN mRNA
CTD
PMID:32076005
NCBI chr 1:153,259,687...153,262,124
Ensembl chr 1:153,259,687...153,262,124
G
LRIG1
leucine rich repeats and immunoglobulin like domains 1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of LRIG1 mRNA
CTD
PMID:28713220
NCBI chr 3:66,378,797...66,501,121
Ensembl chr 3:66,378,797...66,501,263
G
LSS
lanosterol synthase
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of LSS mRNA
CTD
PMID:17547211
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
G
MAFF
MAF bZIP transcription factor F
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of MAFF mRNA
CTD
PMID:17547211
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
G
MAN1A2
mannosidase alpha class 1A member 2
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of MAN1A2 mRNA
CTD
PMID:17547211
NCBI chr 1:117,367,449...117,528,872
Ensembl chr 1:117,367,449...117,528,872
G
MAOA
monoamine oxidase A
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of MAOA mRNA
CTD
PMID:32076005
NCBI chr X:43,655,006...43,746,817
Ensembl chr X:43,654,907...43,746,817
G
MAP2K1
mitogen-activated protein kinase kinase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of MAP2K1 mRNA
CTD
PMID:32076005
NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
ISO EXP
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of MAPK1 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased phosphorylation of MAPK1 protein
CTD
PMID:32076005 PMID:32920012 PMID:34571074
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
ISO EXP
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of MAPK3 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased phosphorylation of MAPK3 protein
CTD
PMID:32076005 PMID:32920012 PMID:34571074
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MCM2
minichromosome maintenance complex component 2
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of MCM2 mRNA
CTD
PMID:17547211
NCBI chr 3:127,598,411...127,622,436
Ensembl chr 3:127,598,410...127,622,436
G
ME1
malic enzyme 1
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of ME1 mRNA
CTD
PMID:28713220
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
MGAT2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of MGAT2 mRNA
CTD
PMID:17547211
NCBI chr14:49,620,799...49,623,481
Ensembl chr14:49,620,799...49,623,481
G
MGST1
microsomal glutathione S-transferase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of MGST1 mRNA
CTD
PMID:32076005
NCBI chr12:16,347,115...16,593,331
Ensembl chr12:16,347,142...16,609,259
G
MT1E
metallothionein 1E
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of MT1E mRNA
CTD
PMID:28713220
NCBI chr16:56,625,781...56,627,112
Ensembl chr16:56,625,475...56,627,112
G
MT1X
metallothionein 1X
decreases expression increases expression
EXP
Antimony Potassium Tartrate results in decreased expression of MT1X mRNA Antimony Potassium Tartrate results in increased expression of MT1X mRNA
CTD
PMID:17547211 PMID:28713220
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
G
MT2A
metallothionein 2A
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of MT2A mRNA
CTD
PMID:28713220
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
G
MYCN
MYCN proto-oncogene, bHLH transcription factor
multiple interactions decreases response to substance
EXP
[MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Antimony Potassium Tartrate MYCN protein results in decreased susceptibility to Antimony Potassium Tartrate
CTD
PMID:10348353
NCBI chr 2:15,940,550...15,947,004
Ensembl chr 2:15,940,550...15,947,007
G
NDRG2
NDRG family member 2
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of NDRG2 mRNA
CTD
PMID:17547211
NCBI chr14:21,016,763...21,070,872
Ensembl chr14:21,016,763...21,070,872
G
NFKB2
nuclear factor kappa B subunit 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of NFKB2 mRNA
CTD
PMID:32076005
NCBI chr10:102,394,110...102,402,529
Ensembl chr10:102,394,110...102,402,524
G
NFKBIA
NFKB inhibitor alpha
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of NFKBIA mRNA
CTD
PMID:17547211
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,513...35,404,749
G
NKX3-1
NK3 homeobox 1
increases expression multiple interactions
EXP
Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA; Antimony Potassium Tartrate results in increased expression of NKX3-1 protein bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA]
CTD
PMID:29462692
NCBI chr 8:23,678,693...23,682,938
Ensembl chr 8:23,678,697...23,682,938
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 mRNA]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein]
CTD
PMID:34571074
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression multiple interactions
EXP
Antimony Potassium Tartrate results in increased expression of NQO1 mRNA; Antimony Potassium Tartrate results in increased expression of NQO1 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of NQO1 mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NQO2
N-ribosyldihydronicotinamide:quinone reductase 2
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of NQO2 mRNA
CTD
PMID:28713220
NCBI chr 6:2,999,894...3,019,755
Ensembl chr 6:2,987,987...3,019,755
G
NR0B2
nuclear receptor subfamily 0 group B member 2
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of NR0B2 mRNA
CTD
PMID:17547211
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
OS9
OS9 endoplasmic reticulum lectin
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of OS9 mRNA
CTD
PMID:17547211
NCBI chr12:57,694,132...57,721,557
Ensembl chr12:57,693,955...57,721,557
G
OSM
oncostatin M
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] inhibits the reaction [OSM protein results in increased phosphorylation of STAT1 protein]
CTD
PMID:32076005
NCBI chr22:30,262,829...30,266,851
Ensembl chr22:30,262,829...30,266,851
G
PBX1
PBX homeobox 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PBX1 mRNA
CTD
PMID:32076005
NCBI chr 1:164,559,184...164,886,047
Ensembl chr 1:164,555,584...164,899,296
G
PCNA
proliferating cell nuclear antigen
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of PCNA protein
CTD
PMID:34571074
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
PDIA4
protein disulfide isomerase family A member 4
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of PDIA4 mRNA
CTD
PMID:17547211
NCBI chr 7:149,003,051...149,028,505
Ensembl chr 7:149,003,062...149,028,662
G
PGC
progastricsin
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of PGC mRNA
CTD
PMID:17547211
NCBI chr 6:41,736,711...41,747,397
Ensembl chr 6:41,736,711...41,754,109
G
PGD
phosphogluconate dehydrogenase
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of PGD protein
CTD
PMID:28713220
NCBI chr 1:10,399,064...10,420,511
Ensembl chr 1:10,398,592...10,420,511
G
PGM1
phosphoglucomutase 1
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of PGM1 mRNA
CTD
PMID:28713220
NCBI chr 1:63,593,411...63,660,245
Ensembl chr 1:63,593,411...63,660,245
G
PGM3
phosphoglucomutase 3
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of PGM3 mRNA
CTD
PMID:28713220
NCBI chr 6:83,148,705...83,193,900
Ensembl chr 6:83,161,150...83,193,936
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PIK3R1 mRNA
CTD
PMID:32076005
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,756...68,301,821
G
PIK3R2
phosphoinositide-3-kinase regulatory subunit 2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PIK3R2 mRNA
CTD
PMID:32076005
NCBI chr19:18,153,163...18,170,532
Ensembl chr19:18,153,163...18,170,532
G
PIR
pirin
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of PIR mRNA
CTD
PMID:32076005
NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564
G
PITX1
paired like homeodomain 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PITX1 mRNA
CTD
PMID:32076005
NCBI chr 5:135,027,734...135,034,789
Ensembl chr 5:135,027,734...135,034,813
G
PML
PML nuclear body scaffold
affects localization multiple interactions increases degradation
EXP
Antimony Potassium Tartrate affects the localization of PML protein Antimony Potassium Tartrate promotes the reaction [SUMO1 protein binds to PML protein] Antimony Potassium Tartrate results in increased degradation of PML protein mutant form
CTD
PMID:9834237
NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827
G
POLR2J2
RNA polymerase II subunit J2
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of POLR2J2 mRNA
CTD
PMID:32076005
NCBI chr 7:102,666,046...102,671,663
Ensembl chr 7:102,665,368...102,671,629
G
PPIH
peptidylprolyl isomerase H
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of PPIH mRNA
CTD
PMID:17547211
NCBI chr 1:42,658,423...42,681,654
Ensembl chr 1:42,658,335...42,676,758
G
PRDX1
peroxiredoxin 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of PRDX1 mRNA
CTD
PMID:32076005
NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
G
PSPH
phosphoserine phosphatase
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of PSPH mRNA
CTD
PMID:17547211
NCBI chr 7:56,011,064...56,051,444
Ensembl chr 7:56,011,051...56,051,604
G
PTTG1
PTTG1 regulator of sister chromatid separation, securin
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of PTTG1 mRNA
CTD
PMID:17547211
NCBI chr 5:160,421,855...160,428,744
Ensembl chr 5:160,421,855...160,428,739
G
RARA
retinoic acid receptor alpha
increases degradation
EXP
Antimony Potassium Tartrate results in increased degradation of RARA protein mutant form
CTD
PMID:9834237
NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643
G
RBPMS
RNA binding protein, mRNA processing factor
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of RBPMS mRNA
CTD
PMID:17547211
NCBI chr 8:30,384,541...30,572,256
Ensembl chr 8:30,384,511...30,572,256
G
RFC2
replication factor C subunit 2
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of RFC2 mRNA
CTD
PMID:17547211
NCBI chr 7:74,231,502...74,254,399
Ensembl chr 7:74,231,499...74,254,458
G
RNASEH2A
ribonuclease H2 subunit A
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of RNASEH2A mRNA
CTD
PMID:17547211
NCBI chr19:12,806,584...12,813,640
Ensembl chr19:12,806,584...12,813,640
G
RNH1
ribonuclease/angiogenin inhibitor 1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of RNH1 protein
CTD
PMID:28713220
NCBI chr11:494,515...507,242
Ensembl chr11:494,512...507,300
G
RPTN
repetin
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of RPTN mRNA
CTD
PMID:28713220
NCBI chr 1:152,153,595...152,159,228
Ensembl chr 1:152,153,595...152,159,228
G
RYR1
ryanodine receptor 1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of RYR1 mRNA
CTD
PMID:28713220
NCBI chr19:38,433,691...38,587,564
Ensembl chr19:38,433,691...38,595,273
G
S100A12
S100 calcium binding protein A12
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of S100A12 mRNA
CTD
PMID:28713220
NCBI chr 1:153,373,711...153,375,621
Ensembl chr 1:153,373,711...153,375,621
G
S100A2
S100 calcium binding protein A2
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of S100A2 mRNA
CTD
PMID:28713220
NCBI chr 1:153,561,108...153,565,844
Ensembl chr 1:153,561,108...153,567,890
G
S100A7
S100 calcium binding protein A7
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of S100A7 mRNA
CTD
PMID:28713220
NCBI chr 1:153,457,744...153,460,651
Ensembl chr 1:153,457,744...153,460,651
G
S100A8
S100 calcium binding protein A8
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of S100A8 mRNA; Antimony Potassium Tartrate results in decreased expression of S100A8 protein
CTD
PMID:28713220
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
G
S100A9
S100 calcium binding protein A9
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of S100A9 mRNA; Antimony Potassium Tartrate results in decreased expression of S100A9 protein
CTD
PMID:28713220
NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023
G
SCD
stearoyl-CoA desaturase
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of SCD mRNA
CTD
PMID:17547211
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
G
SEPHS2
selenophosphate synthetase 2
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of SEPHS2 mRNA
CTD
PMID:17547211
NCBI chr16:30,443,631...30,445,874
Ensembl chr16:30,443,631...30,445,874
G
SERPINB1
serpin family B member 1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of SERPINB1 mRNA
CTD
PMID:17547211
NCBI chr 6:2,832,332...2,841,863
Ensembl chr 6:2,832,332...2,841,959
G
SERPINC1
serpin family C member 1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of SERPINC1 mRNA
CTD
PMID:17547211
NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327
G
SERPINE1
serpin family E member 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SERPINE1 mRNA
CTD
PMID:32076005
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SIK1
salt inducible kinase 1
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of SIK1 mRNA
CTD
PMID:17547211
NCBI chr21:43,414,483...43,427,131
Ensembl chr21:43,414,483...43,427,131
G
SLC2A3
solute carrier family 2 member 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SLC2A3 mRNA
CTD
PMID:32076005
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...7,936,187
G
SNRPA
small nuclear ribonucleoprotein polypeptide A
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of SNRPA mRNA
CTD
PMID:17547211
NCBI chr19:40,751,203...40,765,389
Ensembl chr19:40,750,637...40,765,389
G
SOD1
superoxide dismutase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SOD1 mRNA
CTD
PMID:32076005
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SPRR1A
small proline rich protein 1A
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of SPRR1A mRNA; Antimony Potassium Tartrate results in decreased expression of SPRR1A protein
CTD
PMID:28713220
NCBI chr 1:152,984,081...152,985,814
Ensembl chr 1:152,984,081...152,985,814
G
SPRR1B
small proline rich protein 1B
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of SPRR1B mRNA; Antimony Potassium Tartrate results in decreased expression of SPRR1B protein
CTD
PMID:28713220
NCBI chr 1:153,031,203...153,032,900
Ensembl chr 1:153,031,203...153,032,900
G
SPRR3
small proline rich protein 3
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of SPRR3 mRNA; Antimony Potassium Tartrate results in decreased expression of SPRR3 protein
CTD
PMID:28713220
NCBI chr 1:153,001,749...153,003,856
Ensembl chr 1:153,001,747...153,003,856
G
SQLE
squalene epoxidase
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of SQLE mRNA
CTD
PMID:17547211
NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283
G
SQSTM1
sequestosome 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SQSTM1 mRNA
CTD
PMID:32076005
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
SRSF1
serine and arginine rich splicing factor 1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of SRSF1 mRNA
CTD
PMID:17547211
NCBI chr17:57,989,038...58,007,246
Ensembl chr17:58,000,919...58,007,346
G
SRSF5
serine and arginine rich splicing factor 5
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of SRSF5 mRNA
CTD
PMID:17547211
NCBI chr14:69,767,142...69,772,005
Ensembl chr14:69,726,900...69,772,005
G
SRXN1
sulfiredoxin 1
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of SRXN1 mRNA
CTD
PMID:28713220
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
G
ST6GALNAC4
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of ST6GALNAC4 mRNA
CTD
PMID:17547211
NCBI chr 9:127,907,886...127,917,041
Ensembl chr 9:127,907,886...127,917,041
G
STAT1
signal transducer and activator of transcription 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] inhibits the reaction [OSM protein results in increased phosphorylation of STAT1 protein]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of STAT1 mRNA
CTD
PMID:32076005
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
G
SULT1C3
sulfotransferase family 1C member 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT1C3 mRNA
CTD
PMID:32076005
NCBI chr 2:108,239,968...108,265,351
Ensembl chr 2:108,239,968...108,265,351
G
SULT1E1
sulfotransferase family 1E member 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT1E1 mRNA
CTD
PMID:32076005
NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145
G
SULT2B1
sulfotransferase family 2B member 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT2B1 mRNA
CTD
PMID:32076005
NCBI chr19:48,552,172...48,599,427
Ensembl chr19:48,552,172...48,599,425
G
SUMO1
small ubiquitin like modifier 1
affects localization multiple interactions
EXP
Antimony Potassium Tartrate affects the localization of SUMO1 protein Antimony Potassium Tartrate promotes the reaction [SUMO1 protein binds to PML protein]
CTD
PMID:9834237
NCBI chr 2:202,206,171...202,238,597
Ensembl chr 2:202,206,182...202,238,599
G
TARDBP
TAR DNA binding protein
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of TARDBP mRNA
CTD
PMID:17547211
NCBI chr 1:11,012,654...11,030,528
Ensembl chr 1:11,012,344...11,030,528
G
TGM1
transglutaminase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TGM1 mRNA
CTD
PMID:32076005
NCBI chr14:24,249,114...24,263,177
Ensembl chr14:24,249,114...24,264,432
G
TNFAIP3
TNF alpha induced protein 3
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of TNFAIP3 mRNA
CTD
PMID:17547211
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,312
G
TNFSF10
TNF superfamily member 10
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of TNFSF10 mRNA
CTD
PMID:17547211
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
G
TOB1
transducer of ERBB2, 1
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of TOB1 mRNA
CTD
PMID:17547211
NCBI chr17:50,862,223...50,867,978
Ensembl chr17:50,862,223...50,867,978
G
TP63
tumor protein p63
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TP63 mRNA
CTD
PMID:32076005
NCBI chr 3:189,596,746...189,897,276
Ensembl chr 3:189,631,389...189,897,276
G
TPI1
triosephosphate isomerase 1
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of TPI1 mRNA
CTD
PMID:28713220
NCBI chr12:6,867,420...6,870,948
Ensembl chr12:6,867,119...6,870,948
G
TSC22D3
TSC22 domain family member 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TSC22D3 mRNA
CTD
PMID:32076005
NCBI chr X:107,713,221...107,777,086
Ensembl chr X:107,713,221...107,777,342
G
TSPAN7
tetraspanin 7
decreases expression
EXP
Antimony Potassium Tartrate results in decreased expression of TSPAN7 mRNA
CTD
PMID:17547211
NCBI chr X:38,561,542...38,688,918
Ensembl chr X:38,561,542...38,688,920
G
TUFT1
tuftelin 1
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of TUFT1 mRNA
CTD
PMID:17547211
NCBI chr 1:151,540,309...151,583,583
Ensembl chr 1:151,540,305...151,583,583
G
TXN
thioredoxin
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of TXN mRNA
CTD
PMID:32076005
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
TXNRD1
thioredoxin reductase 1
increases expression multiple interactions
EXP
Antimony Potassium Tartrate results in increased expression of TXNRD1 mRNA [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of TXNRD1 mRNA
CTD
PMID:17547211 PMID:28713220 PMID:32076005
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
TYMS
thymidylate synthetase
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of TYMS mRNA
CTD
PMID:17547211
NCBI chr18:657,653...673,578
Ensembl chr18:657,653...673,578
G
UBE2C
ubiquitin conjugating enzyme E2 C
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of UBE2C mRNA
CTD
PMID:17547211
NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957
G
UGT1A6
UDP glucuronosyltransferase family 1 member A6
increases expression multiple interactions
EXP
Antimony Potassium Tartrate results in increased expression of UGT1A6 mRNA [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of UGT1A6 mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
G
ZWINT
ZW10 interacting kinetochore protein
increases expression
EXP
Antimony Potassium Tartrate results in increased expression of ZWINT mRNA
CTD
PMID:17547211
NCBI chr10:56,357,227...56,361,273
Ensembl chr10:56,357,227...56,361,273
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all